A carregar...

Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease

PURPOSE: Spending for patients with advanced cancer is substantial. Past efforts to characterize this spending usually have not included patients with recurrence (who may differ from those with de novo stage IV disease) or described which services drive spending. METHODS: Using SEER-Medicare data fr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Oncol Pract
Main Authors: Hassett, Michael J., Banegas, Matthew, Uno, Hajime, Weng, Shicheng, Cronin, Angel M., O’Keeffe Rosetti, Maureen, Carroll, Nikki M., Hornbrook, Mark C., Ritzwoller, Debra P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804885/
https://ncbi.nlm.nih.gov/pubmed/31107629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.19.00004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!